Melanotan-I
Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647
A synthetic analog of alpha-melanocyte-stimulating hormone that stimulates melanogenesis, increasing skin pigmentation and providing photoprotection against UV radiation.
Completed
PHASE1, PHASE2
NCT01605383
Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head
Banc de Sang i Teixits
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01920711
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
Novartis Pharmaceuticals
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT02201992
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
ECOG-ACRIN Cancer Research Group
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT01167712
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT00738881
Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT02844816
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT00089323
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
NSABP Foundation Inc
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00770224
S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01776424
Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Bayer
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT02273973
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
Genentech, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NCT05334069
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00534859
PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI
Abiomed Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT02348268
Myofascial Release Therapy and Mechanical Neck Pain
FREMAP Mutual Insurance Company for Occupational Accidents and Diseases
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT02943785
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Daiichi Sankyo
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT02448810
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer
Baxalta now part of Shire
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT01198158
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01802333
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03971474
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03180294
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT03001817
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
Kowa Research Institute, Inc.
INTERVENTIONAL
Updated Dec 15, 2025